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Education and debate
Patient choice modules for summaries of clinical
effectiveness: a proposal
Margaret Holmes-Rovner, Hilary Llewellyn-Thomas, Vikki Entwistle, Angela Coulter,
Annette O’Connor, David R Rovner
Evidence based health care has become the accepted
basis of good clinical practice, and many efforts are
being made to implement it. Evidence based patient
choice, defined as offering patients research based
information and the opportunity to influence deci-
sions about their treatment and care, has yet to achieve
the same status. We believe, however, that it is
fundamental to high quality patient care.
In our ideal world difficult or controversial
healthcare decisions would routinely involve health pro-
fessionals deliberating with patients about the harms
and benefits of all available options, as well as patients’
treatment goals and risk tolerance. For key medical deci-
sions, patients and doctors would expect to work
through the evidence and decide on a course of action
together. Patients who wished to delegate decision mak-
ing to a doctor or surrogate decision maker would still
be given the information that they wanted.
Various strategies may be needed to achieve this
widespread implementation of evidence based patient
choice.1 2 In this article we focus on a strategy to
improve the accessibility of information resources to
support evidence based patient choice. The books,
journals, and websites that currently provide evidence
based information about the effectiveness of health-
care interventions could provide the infrastructure to
support patients’ participation in evidence based deci-
sion making. These information sources should incor-
porate consumer focused summaries of relevant
research evidence and links or pointers to well
designed and tested decision aids for patients. These
summaries should be made available to patients
before, during, and after consultations. Doctors and
health systems could use and distribute them as an
adjunct to clinical care. They would also be available to
the public generally. The news and information media,
patient groups, and others would draw on patient
choice summaries to present the benefits and
limitations of medical screening and treatment.
We suggest that a patient choice module could be
added to systematic reviews and other key assessments
of health technology. Such a module would take
various forms but would be designed to facilitate
patient involvement in decision making. Such modules
would be key data sources for developers of products
like decision aids, leaflets, and interactive websites for
use by patients. They would also be helpful in reorient-
ing thinking across the healthcare system about patient
choice informed by evidence. International collabora-
tion should help the development of appropriate
information to support patient involvement in
treatment decision making.
Need for information
A high degree of patient involvement in clinical
decision making creates a demand for information.3 4
This demand will be met only if the required data are
easily available. Summaries of research evidence about
the effects of healthcare interventions are now becom-
ing accessible to clinicians from sources like Clinical
Evidence5 and the Cochrane Library,6 but these sources
are not designed for patients and are largely inaccessi-
ble to them. Brief consumer synopses are now being
added to Cochrane Collaboration reviews, but these
may not provide enough detail for people facing deci-
sions about their care. More systematic efforts are
needed to develop patient oriented summaries.
Research in ethics,7 the doctor-patient relation-
ship,4 decision analysis,8 shared decision making,9 and
evidence based medicine converge to suggest a
Summary points
Evidence based health care should be
accompanied by evidence based patient choice,
defined as offering patients information about
treatment alternatives, the benefits and harms of
each, and offering patients a key role in decision
making
Evidence based patient choice will increase
demand for patient oriented information about
medical effectiveness.
Time constraints in modern consultations
necessitate that such information be widely
available before, during, and after the consultation
Patient choice modules that follow a standard
template could be added to systematic reviews























































664 BMJ VOLUME 322 17 MARCH 2001 bmj.com
redesign of patient oriented information. Traditionally,
such information makes a recommendation about an
intervention from an authority and then explains how
it works and why it is good for the patient. In contrast,
information to support evidence based patient choice
offers a description of the various possible interven-
tions (including no intervention), a comparison of their
consequences (benefits and harms), and an oppor-
tunity to consider these consequences in relation to life
circumstances and patient preferences. Research on
the efficacy of formal decision aids based on this
approach has shown that they can help patients in sev-
eral ways.10 Patients develop an understanding of what
is involved in a particular treatment choice, are clearer
about what is important to them, and can communi-
cate their preferences to their doctors. As a result, they
gain knowledge, show high satisfaction with their deci-
sions and with the decision making process, and have
less decisional conflict. There is also some evidence
that these aids can modify inordinately high or low use
of healthcare resources.11
The design template for patient oriented
evidence
We suggest a basic template for patient decision mod-
ules that is based on theoretical, methodological, and
evaluative work. A common minimal set of elements
has been found in the diverse tools that have been pro-
duced to support shared decision making.10 12 13 The
key elements of these formal decision aids are a
description of the disease or condition, an outline of
what options are available, and the probabilities of the
beneficial and harmful consequences that follow from
each option for subgroups of the population.
Additional optional elements include a description of
different patients’ experiences with the medical
intervention and its side effects, a rating of the
importance of each outcome that could occur (positive
and negative), guidance on making a follow up plan,
and explicit strategies for communicating with health-
care professionals and partners or families. The data
that can be supplied by systematic reviews are the
available options, the probabilities, and sometimes out-
come descriptions reported as narratives or in terms of
patient values (utilities). Table 1 shows how a patient
decision module could be organised for treatment
options.
Screening poses an additional information burden
because the sensitivity and specificity of the test and the
false positive and false negative rates in tested popula-
tions need to be included. Table 2 shows how the
patient decision module could be organised for
screening options. There is also a strong theoretical
Table 1 Patient decision template for treatment options
Required element Key patient questions Information provided
Clinical condition reported What are the characteristics of my diagnosis/disease/disorder? Details of clinically important subgroups
Patient decision situation What are the different ways this disorder can be treated? Options for surgical treatments, medical
treatments, watchful waiting, complementary
therapies
For each treatment option:
Treatment processes What kind of treatment is it? How much time does it involve?
What do I have to do to undergo this treatment?
Mode and duration of treatment, nature of
patient involvement
Outcomes and probabilities What are the chances of improvement over the next x
days/weeks/months/years or over my lifetime?
Rates for different outcomes over various
times, absolute number improved,
improvement rate
What kinds of side/toxic effects can happen, and what are the
chances of each?
Rates for different side effects
Value tradeoffs What are the tradeoffs between length of life and quality of life?
Material for clarification of values
If length of life is not affected, what are the tradeoffs among the
inconveniences, costs, chances of side effects, etc, in order to
gain a benefit like symptom relief?
Where can I get descriptions of other patients’ experiences?
Table 2 Patient decision template for screening options
Required element Key patient questions Information provided
Clinical condition to be prevented What are the characteristics of this
diagnosis/disease/disorder?
Expected incidence of disease in 1, 5, 10, and 20 years among
untreated patients
Identification of clinically important subgroups at risk
Probabilities of key patient oriented outcomes (harms and
benefits) caused by the disease if untreated
Patient decision situation What are the different ways this disease/disorder can
be detected/prevented?
Options in terms of screening, watchful waiting, medical
preventive strategies, lifestyle preventive strategies
Effectiveness of treatment if detected by
screening
If the disease/disorder is detected by screening how
effective is the subsequent treatment?
Probabilities of key patient oriented harms and benefits, in
terms of difference from rates in unscreened population
Absolute risk reduction
Relative risk reduction
Screening options (for each possible test) What are the side effects of taking this test? Rates of side effects
How accurate is this test? Rates for false positive and negative results
What happens after I take the test? Follow up procedures
Value tradeoffs Am I willing to go through the potential anxiety of
screening and treatment now to prevent a disease in
the future? Material for clarification of values
What impact will screening have on my family and
professional life?
Education and debate
665BMJ VOLUME 322 17 MARCH 2001 bmj.com
and empirical basis for using the same structural com-
ponents that appear in patient decision aids to design
the proposed template for systematic reviews.
The map of opportunities
The figure shows strategic opportunities to add the
proposed patient decision modules to the flow of
health information. In the centre of the map is the
expanding set of electronic networks providing peer
reviewed, credible evidence about the effectiveness of
healthcare interventions. Around it are the potential
end users of medical evidence (such as consumers
seeking information) and intermediary users (such as
developers of patient oriented products like decision
aids). The patient decision modules would be integral
summaries of evidence that the authors of information
summaries and systematic reviews would add (or
cooperate in adding) to their works. The modules
would not usually be added to single studies, since
these rarely provide data on all choices for a given
problem and they do not synthesise previous evidence.
What is needed to make this happen
As the figure suggests, various groups can contribute to
making evidence available in a form that supports
patient choice. The first are the producers of systematic
reviews and other key assessments of health technol-
ogy, including Cochrane Collaboration reviewers and
researchers in evidence based practice centres, who
could add patient decision modules to their products.
Journal editors and publishers could also encourage
and support this effort.
Secondly, producers of major patient websites
(such as NHS Direct Online), the National Electronic
Library for Health,14 Healthfinder,15 Health in Focus,16
Health Insight,17 professional websites,18 19 and volun-
tary organisations and advocacy groups could request
patient decision modules and commission comple-
mentary decision aids. Websites that include patient
decision modules and access to decision aids may
increasingly supply the “one stop” access that
impatient web searchers would like to find.
A third group are the producers of decision aids
and decision support systems such as the Loeb Health
Research Institute20 and Health Dialog,21 who could
continue to develop new products based on the patient
decision modules and offer access to their products via
websites.
The need for integrated healthcare systems is now
recognised, but these need to be supported by
integrated knowledge systems and care management
tools. The transmission of information to support
patient choice needs to be better developed. Health
education and communication have tended to be
dominated by the desire to persuade patients to
comply with treatment. Consumer health information
materials that aim to enable people to understand,
contribute to, and make decisions about their health
care are still rare.22 The implementation of evidence
based patient choice requires continued efforts to
address issues such as how to increase comprehension,
how best to present information about harms and ben-
efits, how to present probability data, and how to com-
municate uncertainty in constructive ways.
Will it work?
The purpose of our proposed patient choice modules
is to bolster the movement to higher standards of
informed consent and patient participation in decision
making. We hope to make routine the implementation
of informed consent standards such as those
recommended by the General Medical Council.23
Some barriers can be anticipated. The addition of
patient decision modules would require extra work and
new skills that are beyond the current capacity of many
information producers. Many will lack some of the data
or skills that are needed to complete the template.24
Information producers could gain training and advice
from credible centres that are independent of vested
interests, in particular healthcare interventions, and
that include multidisciplinary teams with all the neces-
sary skills. These independent centres might also be
commissioned to produce and update modules and
materials based on their reviews.
It is important that these efforts are carried out in
the public domain and that the standards and quality
of patient decision modules and decision aids are
monitored. There is a danger that information might
be presented that seems to offer patients a choice but
does not give all the alternatives or is biased towards a
particular option. The development and use of
credible quality indicators for decision aids would help
protect potential users. Our proposed template
supports such review by establishing a structured
format, but individual modules and decision aids
would need to be assessed in terms of their consistency
with available research evidence and their accessibility
and usefulness to patients. Evaluation and peer review
should serve to improve standards.
Patient websites, publications
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The preferred style of the clinical encounter is
widely assumed to have moved from paternalism to
partnership.25 Empowering consumers is increasingly
seen as a cornerstone of modern health care. Our pro-
posed template is no magic bullet. Information alone
will not change the way the public, health profession-
als, and policy makers deliberate and interact. For
example, the stability of patterns of healthcare practice
tends to countermand efforts to introduce evidence
based patient decision making. Incorporating decision
aids into routine practice in busy medical establish-
ments is difficult,26 and health professionals may resist
attempts to offer patients information and choice.
Appointment systems for health services may need to
be revised to allow time for shared decision making.
However, re-framing medical discourse in terms of
choices to be made and their likely consequences and
in emphasising the importance of patients’ goals and
values is a first step.
The provision of information to patients and the
facilitation of shared decision making may become
measures of health system performance. Greater
patient participation in decision making requires new
and integrated information tools and training of health
professionals so that, rather than adding complexity
and burden, it enhances the health system’s capacity to
provide high quality health care to an informed public.
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A memorable patient
The benefits of attending the dentist
I had only recently given an undergraduate lecture on endocrine
disorders when I was asked to see him. He had been referred by
his dentist to the professor of prosthodontics because the
provision of partial dentures was proving difficult. His mandible
was long and his tongue was large, but it was the chatting about
golf that made the difference. He blamed his golf handicap on his
shoes as they were increasingly cramping his feet, and he
commented that on recently buying a new pair, he found he had
gone up a whole shoe size. The professor’s sixth sense told him
that something may be amiss and I was asked to see the patient.
An inability to get his wedding ring on his finger, a change in
facial appearance, and an increase in collar size all sounded
suspicious. Further questioning revealed a history including
hypertension, late onset diabetes, arthralgia, and bilateral carpel
tunnel syndrome. His facial features were coarse, his hands were
spade-like, and his feet were large. He did not have tunnel vision
but he had enough. An endocrinological investigation quickly
followed.
His acromegaly was confirmed, and he subsequently underwent
successful surgery to remove a pituitary adenoma. His
hypertension and diabetes have resolved and his arthralgia has
improved. The soft tissue swelling of his hands has also
considerably reduced, such that he is once more able to wear his
wedding ring.
The diagnosis of systemic disease in a dental context is an
important part of my work. Dentists have a role in the
opportunistic identification of oral features of systemic disease as
well as important regional and local conditions such as oral
cancer. Indeed, these are some of the reasons why all dental
students undergo teaching and examination in general medicine
and surgery as part of their undergraduate dental degree. For
some of us our interest continues (whether medical or surgical),
and, in addition to our dental training, we later undertake a
medical degree and postgraduate training as our career develops.
I still occasionally see him on the stairs as he ascends to the
prosthodontics clinic. While his acromegaly may have been
treated successfully, the provision of dentures is still proving
problematic, and his golf handicap remains unchanged.
Mike Pemberton consultant in oral medicine, University Dental
Hospital of Manchester, Manchester M15 6FH
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